-
Bharat Biotech studying if Covaxin shot will work on Omicron
expresspharma
December 02, 2021
Bharat Biotech said yesterday it was studying if its Covaxin shot would work against variants of coronavirus such as Omicron, after the CEO of drugmaker Moderna warned that the existing vaccines would be less effective.
-
Scotland expands vaccine rollout in the face of rising Omicron cases
PharmaTimes
December 02, 2021
The Scottish government aims to expand and advance their COVID-19 booster programme, following the six cases of the Omicron variant that were reported as of Monday 29 November. This decision is based on advice from the Joint Committee on Vaccination...
-
Total UK cases of Omicron rise to nine
PharmaTimes
December 01, 2021
An additional six cases of the Omicron variant have now been detected in Scotland, bringing the UK total so far to nine...
-
Everest Medicines and Providence Therapeutics Jointly Announce Vaccine Development Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant
prnasia
December 01, 2021
Everest Medicines and Providence Therapeutics ("Providence") jointly announced today that the companies have started working on a new version of COVID-19 vaccine specifically targeting the new Omicron variant.
-
Vaccines, Boosters Should Protect Against Severe COVID, Even With Omicron: Fauci
Drugs
December 01, 2021
Americans who are vaccinated and boosted against COVID-19 should have enough antibody protection to prevent severe illness if they become infected with the new Omicron variant, White House COVID response officials said Tuesday.
-
Omicron Unlikely to Cause Severe Illness in Vaccinated People, BioNTech Founder Says
FirstWordPharma
December 01, 2021
Several scientists said the new Omicron strain of SARS-CoV-2 could lead to more infections among vaccinated people, but some suggested there were reasons to believe the shots would protect against severe disease...
-
Omicron variant minimally impacts Gritstone’s Covid-19 vaccines
Pharmaceutical-Technology
December 01, 2021
Gritstone bio has reported that the mutations seen within the Omicron (B.1.1.529) variant of the SARS-CoV-2 virus does not affect the viruses’ T cell epitopes (TCEs) delivered along with its self-amplifying...
-
WHO update on Omicron
WorldPharmaNews
December 01, 2021
On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO's Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron...
-
JOYSBIO's SARS-COV-2 Antigen Rapid test detects OMICRON variant
prnasia
November 30, 2021
JOYSBIO, one of the world's leading manufacturers of lateral flow rapid tests, is proud to announce that their tests are available around the world.
-
Vaccine Makers Already Testing Their Shots Against Omicron Variant
Drugs
November 30, 2021
As concerns about the new omicron variant grow, vaccine makers say they are already working on ways to protect people against the potential new threat.